Kogakuin University, with the aim of advancing education and research through collaboration between medicine, pharmacy, and engineering, utilizing the characteristics and academic assets of the university, with Tokyo University of Pharmacy and Pharmacy. Since 2010, it has concluded "Collaboration between 3 Pharmaceutical Engineering Universities". On June 2016, 6, the three universities will deepen their understanding of the fields in which they can collaborate, build more advanced pharmaceutical-engineering collaboration, and bring about synergistic effects. "Promotion Symposium" was held at Tokyo Medical University Hospital.
This time, the fifth time, it will be held under the title of "A New World Expanded by Cooperation in Medical, Pharmaceutical and Engineering". Professor Yukiko Hayashi, Chief of Pathological Physiology, Tokyo Medical University, gave a special lecture entitled "Elucidation of Pathophysiology and Treatment Strategy of Muscle Diseases", followed by Professor Toshihiko Hirano, Department of Clinical Pharmacology, Faculty of Pharmaceutical Sciences, Tokyo University of Pharmacy, "Patient Peripheral Blood". Professor Hisaya Tanaka, Department of Computer Science, Faculty of Informatics, Tokyo University of Pharmacy, gave a lecture on "Tailor-made immunosuppressive therapy based on drug sensitivity of lymphocytes" under the theme of "Character input brain interface based on the needs of ALS people".After that, a poster session and a medicinal engineering exchange meeting were held, and lively exchanges of opinions and research were held by the three universities, which ended with a great success.
In the Abe administration's growth strategy, the medical device field is positioned as one of the growth industries, and industry, academia and government will work together to promote development and export.There is a track record of research on disaster medicine and joint participation in disaster prevention and evacuation training between Kogakuin University and Tokyo Medical University, and since Tokyo Medical University and Tokyo Medical University are sister schools, practical training for pharmaceutical students. There is a history of promoting collaborative activities in education and research.The three universities have signed a partnership, and each has become a base for open innovation in response to the tailwind of the country's growth strategy.Through this symposium, it is expected that further research will be activated in the future.
